CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 60.21 CNY -1.67% Market Closed
Market Cap: 6.9B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
CanSino Biologics Inc

Current Assets 4.5B
Cash & Short-Term Investments 3.5B
Receivables 588.2m
Other Current Assets 421.7m
Non-Current Assets 3.6B
Long-Term Investments 477.1m
PP&E 2.6B
Intangibles 242.7m
Other Non-Current Assets 259m
Current Liabilities 1.9B
Accounts Payable 77.8m
Accrued Liabilities 81m
Short-Term Debt 689.1m
Other Current Liabilities 1B
Non-Current Liabilities 1.2B
Long-Term Debt 1B
Other Non-Current Liabilities 187m

Balance Sheet
CanSino Biologics Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
53
18
57
203
4 447
190
73
2 070
Cash
0
0
0
0
0
0
0
2 046
Cash Equivalents
53
18
57
203
4 447
190
73
24
Short-Term Investments
94
403
140
552
667
2 112
2 482
2 050
Total Receivables
0
3
15
23
137
278
964
647
Accounts Receivables
0
0
0
0
22
158
855
637
Other Receivables
0
0
0
0
115
120
108
10
Inventory
0
2
9
16
171
876
678
353
Other Current Assets
0
2
0
0
0
379
142
61
Total Current Assets
147
427
221
794
5 421
9 290
7 730
5 181
PP&E Net
158
397
507
608
917
2 337
3 204
3 193
PP&E Gross
158
397
507
608
917
2 337
3 204
3 193
Accumulated Depreciation
18
26
36
59
88
122
312
853
Intangible Assets
0
21
32
39
37
198
259
206
Note Receivable
1
2
16
37
108
0
0
53
Long-Term Investments
0
0
0
307
265
45
50
447
Other Long-Term Assets
20
19
19
0
0
3
226
239
Total Assets
326
N/A
866
+166%
796
-8%
1 785
+124%
6 748
+278%
11 874
+76%
11 469
-3%
9 319
-19%
Liabilities
Accounts Payable
1
2
7
6
61
843
220
104
Accrued Liabilities
11
16
29
22
73
224
201
212
Short-Term Debt
0
0
0
0
0
991
1 563
883
Current Portion of Long-Term Debt
0
0
0
29
49
121
94
574
Other Current Liabilities
16
95
71
67
231
683
847
792
Total Current Liabilities
27
113
107
124
413
2 861
2 925
2 565
Long-Term Debt
69
108
150
138
94
263
1 076
1 241
Deferred Income Tax
0
0
0
0
0
1
0
0
Minority Interest
0
0
0
0
0
553
498
13
Other Liabilities
15
38
37
52
171
201
222
225
Total Liabilities
112
N/A
259
+132%
294
+13%
314
+7%
677
+116%
3 879
+473%
4 721
+22%
4 044
-14%
Equity
Common Stock
0
156
161
223
248
247
247
247
Retained Earnings
88
61
179
322
702
1 150
43
1 440
Additional Paid In Capital
130
516
529
1 570
6 525
6 598
6 608
6 574
Treasury Stock
0
0
0
0
0
0
150
106
Other Equity
4
4
8
0
0
0
0
0
Total Equity
215
N/A
607
+183%
502
-17%
1 471
+193%
6 071
+313%
7 995
+32%
6 748
-16%
5 275
-22%
Total Liabilities & Equity
326
N/A
866
+166%
796
-8%
1 785
+124%
6 748
+278%
11 874
+76%
11 469
-3%
9 319
-19%
Shares Outstanding
Common Shares Outstanding
130
156
161
223
247
231
230
230

See Also

Discover More